Growth Metrics

Eli Lilly (LLY) Total Debt (2016 - 2025)

Historic Total Debt for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $42.5 billion.

  • Eli Lilly's Total Debt rose 2633.16% to $42.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $42.5 billion, marking a year-over-year increase of 2633.16%. This contributed to the annual value of $42.5 billion for FY2025, which is 2633.16% up from last year.
  • Latest data reveals that Eli Lilly reported Total Debt of $42.5 billion as of Q4 2025, which was up 2633.16% from $42.5 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Total Debt ranged from a high of $42.5 billion in Q3 2025 and a low of $15.9 billion during Q3 2022
  • For the 5-year period, Eli Lilly's Total Debt averaged around $24.9 billion, with its median value being $19.5 billion (2023).
  • Per our database at Business Quant, Eli Lilly's Total Debt tumbled by 700.6% in 2022 and then surged by 5534.16% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Total Debt stood at $16.9 billion in 2021, then fell by 3.83% to $16.2 billion in 2022, then surged by 55.34% to $25.2 billion in 2023, then skyrocketed by 33.37% to $33.6 billion in 2024, then increased by 26.33% to $42.5 billion in 2025.
  • Its Total Debt stands at $42.5 billion for Q4 2025, versus $42.5 billion for Q3 2025 and $39.9 billion for Q2 2025.